Stroke Prevention in Atrial Fibrillation

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
For this podcast, produced by the American Society of Health-System Pharmacists, 3 pharmacists were interviewed on issues relating to preventing stroke in atrial fibrillation. The interviewees are: James Kalus, PharmD, senior manager of patient care services in the department of pharmacy at Henry Ford Hospital in Detroit; Cynthia Sanoski, PharmD, chair and associate professor in the department of pharmacy practice at Jefferson School of Pharmacy at Thomas Jefferson University in Philadelphia; and Nancy Shapiro, PharmD, clinical associate professor in the department of pharmacy practice at the University of Illinois at Chicago College of Pharmacy.
 
To listen to this podcast, click here.
Related Articles
Teva has launched a generic version of aspirin and extended-release dipyridamole (Aggrenox) capsules in the United States.
Many states implement unlawful and life-threatening restrictions on Medicaid coverage for the hepatitis C virus drug, sofosbuvir.
John Moorman, PharmD, BCPS, Pharmacist at Akron General Medical Center in Ohio discusses other valuable information about transitions of care programs.
The Supreme Court has ruled to allow states to continue using the controversial lethal injection drug, midazolam.
Latest Issues
$auto_registration$